title: How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy?
authors.affiliation: University of Alabama at Birmingham, Birmingham, AL, USA.
authors.forename: Graciela S
authors.initials: GS
authors.lastname: Alarcón
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D000962:Antimalarials; D006886:Hydroxychloroquine